Cisplatin-Based First-Line Therapy for Advanced Urothelial Carcinoma After Previous Perioperative Cisplatin-Based Therapy

Longer time from previous perioperative chemotherapy (TFPC) ≥ 78 weeks and Eastern Cooperative Oncology Group (ECOG) performance status (PS) = 0 were independently prognostic for better survival with cisplatin-based first-line chemotherapy for advanced urothelial carcinoma (UC) after previous periop...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Genitourin Cancer
Main Authors: Necchi, Andrea, Pond, Gregory R., Giannatempo, Patrizia, Di Lorenzo, Giuseppe, Eigl, Bernhard J., Locke, Jenn, Pal, Sumanta K., Agarwal, Neeraj, Poole, Austin, Vaishampayan, Ulka N., Niegisch, Guenter, Hussain, Syed A., Singh, Parminder, Bellmunt, Joaquim, Sonpavde, Guru
Format: Artigo
Sprog:Inglês
Udgivet: 2014
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4477939/
https://ncbi.nlm.nih.gov/pubmed/25450035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2014.08.010
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker